Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
British Journal of Haematology|April 4, 2019
Outcomes of second allogeneic haematopoietic stem cell transplantation in patients with relapse of myelodysplastic syndromeYoshimitsu Shimomura, Masahiko Hara, Takayoshi Tachibana, et al.
Bone Marrow Transplantation|September 7, 2021
Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysisShuhei Kurosawa, Yoshimitsu Shimomura, Hidehiro Itonaga, et al.
Bone Marrow Transplantation|April 4, 2025
Improved post-transplant outcomes for elderly acute myeloid leukemia patients conditioned with FLU/BU4 rather than conventional MAC regimensTakuya Shimizu, Yasuyuki Arai, Tadakazu Kondo, et al.
International Journal of Hematology|May 20, 2025
Impact of center volume on acute graft versus host disease in allogeneic stem cell transplant recipientsYoshimitsu Shimomura, Seitaro Terakura, Keitaro Matsuo, et al.
Transplantation and Cellular Therapy|January 13, 2024
Impact of Center Volume on Chronic Graft Versus Host Disease in Patients With Allogeneic Stem Cell TransplantationYoshimitsu Shimomura, Tetsuhisa Kitamura, Makoto Murata, et al.
Transplantation and Cellular Therapy|March 17, 2022
Myeloablative Versus Reduced-Intensity Conditioning With Fludarabine/Busulfan for Myelodysplastic Syndrome: A Propensity Score-Matched AnalysisShuhei Kurosawa, Yoshimitsu Shimomura, Hidehiro Itonaga, et al.
Pageof 10